GnRH Agonist

8 Drugs classified under this drug class

GnRH Agonist. Triptorelin Acetate 0.1 mg/ml.
PFS: 0.1 mg/ml. See lit.
Lowers sexual hormones, precocious
puberty, endometriosis,
uterusleiomyoma, IVF.

GnRH Agonist. Triptorelin Acetate 3.75 mg.
MICROCAPSULES C.R: 1 kit x 3.75 mg. 1
I.M. inject. mthly. See lit.
Lowers sexual hormones, precocious
puberty, endometriosis,
uterusleiomyoma, IVF.

GnRH Agonist. Triptorelin Embonate 11.25 mg.
VIAL (pwdr. + solv.): 1 x 11.25 mg. 1 x
every 12 wks, I.M.
Prostat. cancer, lower. sex hormones.

GnRH Agonist. Triptorelin Embonate 22.5 mg.

GnRH Agonist. Triptorelin Embonate 3.75 mg.
VIAL (pwdr. + solv.): 1 x 3.75 mg. 1 x
every 4 weeks, I.M.
Precocious puberty; Prostat. cancer, lower. sex hormones.

GnRH Agonist. Leuprorelin Acetate 11.25 mg.
PREFILLED DUAL CHAMBER SYRINGE
(PDS): 1 x 3.75 mg, 11.25 mg/vial.
3.75 mg mthly.; 11.25 mg/vial: every 3
mths. Both I.M. or S.C. See lit.
Prostat. carcinoma, endometrios., uterine
fibroids (for up to 6 mths.). Tmt breast
cancer in pre/peri-menopaus. women in
whom hormone ther. is specified.
C/I: Hypersens. to the product or similar
nonapeptides; Anaphylaxis; Undiagn.
abnorm. vag. bleed.; Pregn.; Lact.
Additionaly, the 11.25 mg formulation:
pts follow. an orchiectomy.